ProQR Therapeutics
Price & Volume
Stats
See more52W Range | $1.07-$3.97 |
Market Cap | $226.4M |
Shares Short | 778,119 |
Financials
See moreRevenue (12 Mos) | $16M |
Revenue Growth (YoY) | -26.8% |
Gross Profit (12 Mos) | $16M |
Diluted EPS | -$0.47 |
News
See moreYahoo Finance • 4 days ago
Butterfly Network, Citius Pharma Drive Biotech Momentum In After-Hours Trading
Yahoo Finance • 22 days ago
ProQR Announces Third Quarter 2025 Operating and Financial Results
Yahoo Finance • last month
ProQR Receives CTA Authorization for AX-0810 and Announces Virtual Investor and Analyst Event on November 3, 2025
Yahoo Finance • 2 months ago
ProQR to Participate in Upcoming Investor Conferences in October 2025
About
CEO | Mr. Daniel Anton de Boer |
Address | Zernikedreef 9, Leiden, Netherlands, 2333 CK |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 166 |
